WO1994004184A3 - Procede pour ralentir le vieillissement de la peau - Google Patents

Procede pour ralentir le vieillissement de la peau Download PDF

Info

Publication number
WO1994004184A3
WO1994004184A3 PCT/US1993/007470 US9307470W WO9404184A3 WO 1994004184 A3 WO1994004184 A3 WO 1994004184A3 US 9307470 W US9307470 W US 9307470W WO 9404184 A3 WO9404184 A3 WO 9404184A3
Authority
WO
WIPO (PCT)
Prior art keywords
senescence
cutaneous senescence
decreasing
decreasing cutaneous
human
Prior art date
Application number
PCT/US1993/007470
Other languages
English (en)
Other versions
WO1994004184A2 (fr
Inventor
Gregory L Brown
Original Assignee
Bays Brown Dermatologics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bays Brown Dermatologics Inc filed Critical Bays Brown Dermatologics Inc
Priority to AU50017/93A priority Critical patent/AU5001793A/en
Publication of WO1994004184A2 publication Critical patent/WO1994004184A2/fr
Publication of WO1994004184A3 publication Critical patent/WO1994004184A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1808—Epidermal growth factor [EGF] urogastrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

On ralentit la sénescence des cellules épidermiques et par conséquent le vieillissement de la peau chez l'homme, en procédant à l'administration topique sur la peau d'une quantité efficace d'un facteur de croissance aux protéines contenu éventuellement dans un excipient pharmaceutiquement acceptable ou acceptable sur le plan cosmétique.
PCT/US1993/007470 1992-08-12 1993-08-10 Procede pour ralentir le vieillissement de la peau WO1994004184A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU50017/93A AU5001793A (en) 1992-08-12 1993-08-10 Method of decreasing cutaneous senescence

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92826492A 1992-08-12 1992-08-12
US07/928,264 1992-08-12

Publications (2)

Publication Number Publication Date
WO1994004184A2 WO1994004184A2 (fr) 1994-03-03
WO1994004184A3 true WO1994004184A3 (fr) 1994-06-23

Family

ID=25455979

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/007470 WO1994004184A2 (fr) 1992-08-12 1993-08-10 Procede pour ralentir le vieillissement de la peau

Country Status (2)

Country Link
AU (1) AU5001793A (fr)
WO (1) WO1994004184A2 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002807B (el) 1996-06-20 1997-11-13 Lavipharm A.E. Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
US6306432B1 (en) * 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
FR2828401B1 (fr) * 2001-08-10 2003-11-07 Oreal Composition cosmetique ou dermatologique comprenant une association entre l'igf1 et/ou un compose mimetique de l'igf1, et l'acide ascorbique et/ou au moins l'un de ses derives
FR2828400B1 (fr) * 2001-08-10 2003-11-07 Oreal Composition cosmetique ou dermatologique comprenant une association entre de l'igf1 et/ou un compose mimetique de l'igf1, et au moins un retinoide et/ou au moins un derive de retinoide
US6821524B2 (en) * 2002-06-03 2004-11-23 Jan Marini Skin Research, Inc. Cosmetic skin care compositions
FR2854328B1 (fr) * 2003-04-29 2006-08-04 Rocher Yves Biolog Vegetale Composition cosmetique ou dermatologique ou pharmaceutique contenant un facteur de croissance du type vegetal de nature peptidique
US20080234194A1 (en) * 2007-03-20 2008-09-25 Harold Brem Growth factor mediated cosmeceuticals and use thereof to enhance skin quality
EP2139447A2 (fr) 2007-03-20 2010-01-06 Harold Brem Compositions gm-csf cosméceuticales et leurs procédés d'utilisation
US9808654B2 (en) 2013-02-11 2017-11-07 Jan Marini Skin Research Post procedure skin care gel and methods of use thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615006A (ja) * 1984-06-19 1986-01-10 Sanki Shoji Kk 皮膚用剤
JPS6115810A (ja) * 1984-06-30 1986-01-23 Nonogawa Shoji:Kk 化粧料
JPS6219511A (ja) * 1985-07-19 1987-01-28 Kanebo Ltd 皮膚老化防止化粧料
FR2654342A1 (fr) * 1989-11-16 1991-05-17 Sodichimic Sa Composition pharmaceutique et/ou cosmetique contenant un facteur de croissance hypophysaire (hdgf) stabilise par de l'elastine soluble.
EP0444638A2 (fr) * 1990-02-27 1991-09-04 FIDIA S.p.A. Procédé d'expression de facteur de croissance de nerf humain en cellules d'arthropoda frugiperda par infection avec baculovirus recombinant
WO1991018999A1 (fr) * 1990-06-04 1991-12-12 Levin Robert H Produits analogues au facteur de croissance epidermique/urogastrone derives de levures
JPH0429916A (ja) * 1990-05-24 1992-01-31 Shiseido Co Ltd 皮膚外用剤
JPH04145100A (ja) * 1990-10-05 1992-05-19 Earth Chem Corp Ltd イヌ上皮細胞成長因子、該イヌ上皮細胞成長因子を有効成分とする抗炎症剤又は化粧料、及び該イヌ上皮細胞成長因子ｃＥＧＦの製造方法
JPH0543442A (ja) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd 皮膚化粧料

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS615006A (ja) * 1984-06-19 1986-01-10 Sanki Shoji Kk 皮膚用剤
JPS6115810A (ja) * 1984-06-30 1986-01-23 Nonogawa Shoji:Kk 化粧料
JPS6219511A (ja) * 1985-07-19 1987-01-28 Kanebo Ltd 皮膚老化防止化粧料
FR2654342A1 (fr) * 1989-11-16 1991-05-17 Sodichimic Sa Composition pharmaceutique et/ou cosmetique contenant un facteur de croissance hypophysaire (hdgf) stabilise par de l'elastine soluble.
EP0444638A2 (fr) * 1990-02-27 1991-09-04 FIDIA S.p.A. Procédé d'expression de facteur de croissance de nerf humain en cellules d'arthropoda frugiperda par infection avec baculovirus recombinant
JPH0429916A (ja) * 1990-05-24 1992-01-31 Shiseido Co Ltd 皮膚外用剤
WO1991018999A1 (fr) * 1990-06-04 1991-12-12 Levin Robert H Produits analogues au facteur de croissance epidermique/urogastrone derives de levures
JPH04145100A (ja) * 1990-10-05 1992-05-19 Earth Chem Corp Ltd イヌ上皮細胞成長因子、該イヌ上皮細胞成長因子を有効成分とする抗炎症剤又は化粧料、及び該イヌ上皮細胞成長因子ｃＥＧＦの製造方法
JPH0543442A (ja) * 1991-08-14 1993-02-23 Sansho Seiyaku Co Ltd 皮膚化粧料

Non-Patent Citations (12)

* Cited by examiner, † Cited by third party
Title
C.C.CHUA ET AL.: "RECEPTOR FOR EPIDERMAL GROWTH FACTOR RETAINS NORMAL STRUCTURE AND FUNCTION IN AGING CELLS", MECHANISMS OF AGEING AND DEVELOPMENT, vol. 34, no. 1, March 1986 (1986-03-01), pages 35 - 55, XP025196818, DOI: doi:10.1016/0047-6374(86)90103-X *
CHEMICAL ABSTRACTS, vol. 104, no. 20, 19 May 1986, Columbus, Ohio, US; abstract no. 174377J *
CHEMICAL ABSTRACTS, vol. 104, no. 22, 2 June 1986, Columbus, Ohio, US; abstract no. 192928U *
CHEMICAL ABSTRACTS, vol. 106, no. 22, 1 June 1987, Columbus, Ohio, US; abstract no. 182467V *
CHEMICAL ABSTRACTS, vol. 115, no. 17, 28 October 1991, Columbus, Ohio, US; abstract no. 176096T *
CHEMICAL ABSTRACTS, vol. 116, no. 24, 15 June 1992, Columbus, Ohio, US; abstract no. 241736P *
CHEMICAL ABSTRACTS, vol. 117, no. 22, 30 November 1992, Columbus, Ohio, US; abstract no. 219741K *
DATABASE WPI Derwent World Patents Index; AN 1993-104177 *
K.KADOWAKI: "DEVELOPMENT OF NEW HOST FOR GENE RECOMBINATION AND POSSIBILITY OF APPLICATION TO COSMETIC PRODUCTS", FRAGRANCE J., vol. 19, no. 7, 1991, pages 99 - 102 *
M.D.HOLLENBERG ET AL.: "RECEPTORS FOR INSULIN AND EPIDERMAL GROWTH FACTOR-UROGASTRONE IN ADULT HUMAN FIBROBLASTS DO NOT CHANGE WITH DONOR AGE", MECH.AGEING DEV., vol. 11, no. 1, August 1979 (1979-08-01), pages 37 - 43, XP023427172, DOI: doi:10.1016/0047-6374(79)90062-9 *
SIR G. ALLEN: "Cosmetics - chemical technology or biotechnology?", INTERNATIONAL JOURNAL OF COSMETIC SCIENCE, vol. 6, no. 2, April 1984 (1984-04-01), pages 61 - 69 *
T.KAWAMOTO ET AL.: "TRANSFORMING GROWTH FACTOR TYPE BETA STIMULATES EPIDERMAL GROWTH FACTOR-DEPENDENT CELL GROWTH OF in vivo AND in vitro SENESCENT HUMAN SKIN FIBROBLASTS.", CELL STRUCT. FUNCT., vol. 13, no. 6, 1988, pages 616 *

Also Published As

Publication number Publication date
AU5001793A (en) 1994-03-15
WO1994004184A2 (fr) 1994-03-03

Similar Documents

Publication Publication Date Title
AU5789990A (en) Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
AU3393993A (en) Method of administering proteins to living skin cells
AU3232889A (en) Anti-inflammatory skin moisturizing composition and method of preparing same
ZA893564B (en) Cosmetic composition
CA2077144A1 (fr) Composition cosmetique
AU3232589A (en) Skin cleansing and moisturizing composition and method of using and preparing same
EP0255364A3 (fr) Composition cosmétique anhydre
CA2159985A1 (fr) Methodes d'utilisation de l'hesperetine pour le controle du sebum et le traitement de l'acne
AU548324B2 (en) Biotin antagonist composition for use on skin and hair
DE59410301D1 (de) Topische zubereitungen mit einem gehalt an l-arginin
NZ513154A (en) Therapeutic and/or cosmetic formulations comprising antisense polynucleotides to connexin proteins
AU581121B2 (en) Skin treatment composition
AU674142B2 (en) Use of cosmetic composition
WO1994004184A3 (fr) Procede pour ralentir le vieillissement de la peau
CA2207783A1 (fr) Composition desodorisante ou antisudorifique contenant une creme hydratante
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
IT1258069B (it) Composizione per uso topico avente attivita' di stimolo per la ricrescita, di rinvigorimento, di prevenzione dell'ingrigimento e di ripigmentazione naturale dei capelli
CA2016351A1 (fr) Compose cosmetique
AU7395487A (en) Inhibitors of esterase-producing micro-organisms, for use primarily in dermatology and cosmetics
AU6113286A (en) Epidermal cell extracts and method to enhance wound healing and regenerate epidermis
EP0352894A3 (fr) Production d'une composition cosmétique ou pharmaceutique
EP0398669A3 (fr) Composition cosmetique
AU5405996A (en) Improvements in or relating to cosmetic treatment of skin li nes
AU1394392A (en) Hydroxyacids for topical treatment of wrinkles and skin changes associated with aging

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AT AU BB BG BR BY CA CH CZ DE DK ES FI GB HU JP KP KR KZ LK LU MG MN MW NL NO NZ PL PT RO RU SD SE SK UA VN

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase